Skip to main content

UPDATE 2-U.S. FDA approves Amgen drug for prevention of migraines

May 17 (Reuters) - Amgen Inc won U.S. Food and Drug Administration approval on Thursday for the first drug to prevent migraine headaches in adults.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.